Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Page 1
Effects of anti-Xa activity monitoring on the outcome of high-risk pregnancies treated with a prophylactic dose of low-molecular-weight heparin.
Nasich LL, Hoffman R, Keren-Politansky A, Jabareen A, Kalish Y, Schliamser L, Brenner B, Nadir Y. Nasich LL, et al. Among authors: brenner b. Eur J Haematol. 2023 Oct;111(4):655-661. doi: 10.1111/ejh.14060. Epub 2023 Aug 2. Eur J Haematol. 2023. PMID: 37533300
Twenty-eight percent of anti-Xa measurements in the second trimester were beneath the prophylactic threshold, compared to 11% and 16% in the first and third trimesters, respectively (p = .02). Labors ended with live birth in 91% versus 94% of cases (p = .5), 85% versus 68% …
Twenty-eight percent of anti-Xa measurements in the second trimester were beneath the prophylactic threshold, compared to 11% and 16% in the …
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K; Blood Pressure Lowering Treatment Trialists' Collaboration. Nazarzadeh M, et al. Lancet Diabetes Endocrinol. 2022 Sep;10(9):645-654. doi: 10.1016/S2213-8587(22)00172-3. Epub 2022 Jul 22. Lancet Diabetes Endocrinol. 2022. PMID: 35878651 Free PMC article.
Trials exclusively on participants with heart failure or with short-term therapies and acute myocardial infarction or other acute settings were excluded. ...
Trials exclusively on participants with heart failure or with short-term therapies and acute myocardial infarction or other acute set …
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE). …
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isola …
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
Trujillo-Santos J, Farge-Bancel D, Pedrajas JM, Gómez-Cuervo C, Ballaz A, Braester A, Mahé I, Villalobos A, Porras JA, Monreal M; RIETE Investigators. Trujillo-Santos J, et al. Res Pract Thromb Haemost. 2022 Jun 3;6(4):e12736. doi: 10.1002/rth2.12736. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35664535 Free PMC article.
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. ...
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin …
Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism.
Siniscalchi C, Muriel A, Suriñach Caralt JM, Bikdeli B, Jiménez D, Lobo JL, Amado C, Gil-Díaz A, Imbalzano E, Monreal M; the RIETE Investigators. Siniscalchi C, et al. J Thromb Haemost. 2022 Aug;20(8):1839-1851. doi: 10.1111/jth.15753. Epub 2022 May 22. J Thromb Haemost. 2022. PMID: 35510755 Free article.
BACKGROUND: Statins possess antithrombotic and profibrinolytic properties. The association between statin use and short-term outcomes in patients with acute pulmonary embolism (PE) remains unknown. ...
BACKGROUND: Statins possess antithrombotic and profibrinolytic properties. The association between statin use and short-term outcomes …
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials.
Canoy D, Copland E, Nazarzadeh M, Ramakrishnan R, Pinho-Gomes AC, Salam A, Dwyer JP, Farzadfar F, Sundström J, Woodward M, Davis BR, Rahimi K; Blood Pressure Lowering Treatment Trialists' Collaboration; Blood Pressure Lowering Treatment Trialists Collaboration. Canoy D, et al. Heart. 2022 Jul 27;108(16):1281-1289. doi: 10.1136/heartjnl-2021-320171. Heart. 2022. PMID: 35058294 Free PMC article.
OBJECTIVE: Evidence from randomised trials of pharmacological treatments on long-term blood pressure (BP) reduction is limited. We investigated the antihypertensive drug effects on BP over time and across different participant characteristics. ...Appropriate treatment stra …
OBJECTIVE: Evidence from randomised trials of pharmacological treatments on long-term blood pressure (BP) reduction is limited. We in …
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-effectiveness Analysis.
McCandlish JA, Feizullayeva C, Spyropoulos AC, Cronin PP, Naidich JJ, Brenner B, McGinn T, Sanelli PC, Cohen SL. McCandlish JA, et al. Among authors: brenner b. Chest. 2022 Jun;161(6):1628-1641. doi: 10.1016/j.chest.2021.11.036. Epub 2021 Dec 14. Chest. 2022. PMID: 34914975
Our model accounted for risk stratification, empiric treatment, diagnostic testing strategies, as well as short- and long-term effects from PE, treatment with low-molecular-weight heparin, and radiation exposure from advanced imaging. ...
Our model accounted for risk stratification, empiric treatment, diagnostic testing strategies, as well as short- and long-term effect …
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives.
Falanga A, Gal GL, Carrier M, Abdel-Razeq H, Ay C, Martin AJM, Rocha ATC, Agnelli G, Elalamy I, Brenner B. Falanga A, et al. Among authors: brenner b. TH Open. 2021 Aug 31;5(3):e376-e386. doi: 10.1055/s-0041-1736037. eCollection 2021 Jul. TH Open. 2021. PMID: 34485812 Free PMC article.
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these patients. Long-term therapy with low-molecular-weight heparins (LMWHs) has been the standard of care for the treatment of cancer-associa …
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these pat …
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2021 May 1;397(10285):1625-1636. doi: 10.1016/S0140-6736(21)00590-0. Lancet. 2021. PMID: 33933205 Free PMC article.
Trials exclusively done with participants with heart failure or short-term interventions in participants with acute myocardial infarction or other acute settings were excluded. ...
Trials exclusively done with participants with heart failure or short-term interventions in participants with acute myocardial infarc …
Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases.
Verter E, Berger Y, Perl G, Peretz I, Tovar A, Morgenstern S, Brenner B, Benchimol D, Kashtan H, Sadot E. Verter E, et al. Among authors: brenner b. Ann Surg Oncol. 2021 Aug;28(8):4320-4329. doi: 10.1245/s10434-021-10000-6. Epub 2021 Apr 22. Ann Surg Oncol. 2021. PMID: 33886020
BACKGROUND: Studies have suggested that neutrophil-to-lymphocyte ratio (NLR) has value as a predictor of long-term outcomes in various cancer types. Its prognostic potential in patients with CRLM has not been thoroughly investigated. ...
BACKGROUND: Studies have suggested that neutrophil-to-lymphocyte ratio (NLR) has value as a predictor of long-term outcomes in variou …
91 results